Statute Details
- Title: Medicines (Veterinary Medicinal Products) (Exemption) Order
- Act Code: MA1975-OR1
- Legislative Type: Subsidiary Legislation (sl)
- Authorising Act: Medicines Act (Chapter 176), Section 9
- Key Provisions (from extract): Section 1 (Citation); Section 2 (Exemption)
- Commencement Date: Not stated in the provided extract (historical citation indicates [24th June 1977])
- Current Version Status: Current version as at 27 Mar 2026 (per provided metadata)
- Revised Editions Mentioned: 25 Mar 1992 (1990 RevEd); 31 Jan 2000 (2000 RevEd)
- Gazette Citation (as shown): G.N. No. S 143/1977
What Is This Legislation About?
The Medicines (Veterinary Medicinal Products) (Exemption) Order is a short piece of subsidiary legislation made under the Medicines Act (Cap. 176). In plain terms, it creates a specific regulatory exemption for veterinary medicinal products. The practical effect is that a particular prohibition in the Medicines Act—relating to manufacture and wholesale dealing of medicinal products—does not apply to veterinary medicinal products.
Singapore’s medicines regulatory framework is designed to control the manufacture, distribution, and handling of medicinal products to protect public health and safety. However, the regulatory approach can differ depending on the category of product and the risks involved. This Order reflects a legislative decision that veterinary medicinal products should be treated differently for the purposes of the specific prohibition in Section 6 of the Medicines Act.
Although the extract provided contains only two provisions, the legal significance is substantial: it carves out a class of products from a core restriction. For practitioners, the key is to understand what exactly is exempted, which statutory prohibition is affected, and how this interacts with other provisions of the Medicines Act and related regulatory requirements (such as licensing, registration, or other controls that may still apply).
What Are the Key Provisions?
Section 1 (Citation) is a standard provision. It authorises the short title by which the Order may be cited: the “Medicines (Veterinary Medicinal Products) (Exemption) Order.” While not substantive, citation provisions matter for legal drafting and for locating the instrument in practice, especially when counsel must reference it in submissions, compliance advice, or regulatory correspondence.
Section 2 (Exemption) is the operative clause. It states that Section 6 of the Medicines Act—described in the extract as “prohibition against manufacture and wholesale dealing of medicinal product”—shall not apply to veterinary medicinal products.
In practical terms, Section 2 does two things at once:
- Identifies the affected prohibition: the exemption is tied specifically to Section 6 of the Medicines Act.
- Defines the beneficiary category: the exemption applies to veterinary medicinal products.
Because the Order is narrowly drafted, it is important for lawyers to avoid over-reading it. The exemption is not stated as a general exemption from the entire Medicines Act. Instead, it is an exemption from a particular prohibition—“manufacture and wholesale dealing”—contained in Section 6. That means other obligations in the Medicines Act may still apply to veterinary medicinal products, depending on their scope (for example, provisions dealing with registration, labelling, sale, importation, or licensing—if those provisions are not similarly exempted).
Another key interpretive point is the phrase “shall not apply.” This is a strong statutory formulation. It indicates that, for veterinary medicinal products, the prohibition in Section 6 is legally inoperative. Accordingly, conduct that would otherwise breach Section 6 may not be unlawful solely by reason of that prohibition—though it may still be regulated under other parts of the Medicines Act or under other legislation (including licensing regimes, animal health regulations, or general trade controls).
How Is This Legislation Structured?
The Order is extremely concise and consists of:
- Section 1 (Citation): provides the short title.
- Section 2 (Exemption): provides the substantive exemption by disapplying Section 6 of the Medicines Act to veterinary medicinal products.
There are no additional parts or schedules in the extract. The structure suggests that the legislative intent is targeted: rather than creating a comprehensive regulatory framework for veterinary products, the Order simply removes a specific prohibition for a defined category.
Who Does This Legislation Apply To?
The exemption is directed at the legal effect of Section 6 of the Medicines Act. Therefore, it primarily affects persons who would otherwise be caught by the prohibition against manufacture and wholesale dealing of medicinal products, but only to the extent their activities relate to veterinary medicinal products.
In practice, this will be relevant to entities such as veterinary pharmaceutical manufacturers, importers, distributors, and wholesalers dealing in veterinary medicines. However, the exemption does not automatically mean that all regulatory requirements are removed. Lawyers should treat the Order as a partial exemption: it disapplies one prohibition, not necessarily the entire statutory scheme.
Why Is This Legislation Important?
Even though the Order is short, it can have significant commercial and compliance consequences. A prohibition on manufacture and wholesale dealing is a major regulatory lever. If that prohibition does not apply to veterinary medicinal products, the compliance risk profile changes for businesses in that sector. For example, counsel advising on distribution models, supply chain arrangements, or manufacturing arrangements for veterinary products must assess whether the relevant activities fall within the definition of “veterinary medicinal products” and whether the exemption neutralises the Section 6 prohibition.
From an enforcement perspective, the Order clarifies that regulators cannot rely on Section 6 to prosecute or penalise conduct involving veterinary medicinal products. This is important for legal certainty: regulated parties can structure their operations with a clearer understanding of what is prohibited and what is not.
However, practitioners should also be cautious. Because the exemption is limited to Section 6, other statutory controls may still apply. In advising clients, lawyers should conduct a “provision-by-provision” analysis of the Medicines Act to determine whether other requirements—such as licensing, registration, conditions of sale, labelling standards, import controls, or record-keeping—remain applicable to veterinary medicinal products. The Order’s narrow drafting means that compliance cannot be assumed merely because Section 6 is disapplied.
Related Legislation
- Medicines Act (Chapter 176) — in particular Section 6 (prohibition against manufacture and wholesale dealing of medicinal products) and the authorising provision in Section 9.
Source Documents
This article provides an overview of the Medicines (Veterinary Medicinal Products) (Exemption) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.